Aclaris Therapeutics (NasdaqGS:ACRS) FY Conference Transcript

Aclaris Therapeutics (NasdaqGS:ACRS) FY Conference February 26, 2026 08:40 AM ET Company ParticipantsHugh Davis - President, COO and Member of the Board of DirectorsJesse Hall - Chief Medical OfficerNone - Company RepresentativeConference Call ParticipantsJeff Jones - Senior AnalystJeff JonesGood morning, everyone, and welcome back to day two of Oppenheimer's Annual Healthcare Conference. I'm Jeff Jones, one of the senior analysts on the team here, and I'm delighted to welcome multiple members from the Acla ...